Welcome to our dedicated page for ROCKET DOCTOR AI news (Ticker: AIRDF), a resource for investors and traders seeking the latest updates and insights on ROCKET DOCTOR AI stock.
Rocket Doctor AI Inc. reports developments tied to its physician-led, AI-powered healthcare technology business and its wholly owned Rocket Doctor Inc. digital health platform and marketplace. Company news commonly covers U.S. payer network agreements, state-by-state access expansion, physician services delivered through the platform, and updates to primary care, chronic disease management, preventive care, virtual urgent care, and specialist coordination.
Recurring announcements also address financial results, product and engineering capacity, equity-based compensation, clinical AI initiatives, and the Global Library of Medicine decision support system. The company’s completed acquisition of Alea Health Holdings Ltd. adds conversational AI-powered mental health capabilities to its healthcare technology profile.
Rocket Doctor AI (AIRDF) issued an interim operational update on U.S. performance for July–August 2026 ahead of its September 14 global Town Hall.
Completed U.S. patient visits reached 3,625 for the two months ended August 31, 2026, equal to 93% of the 3,911 completed visits in the entire Q2 2026 three‑month period. U.S. clinical hours increased to 1,555 hours over the same two‑month period, reaching 78% of the 1,987.5 clinical hours recorded in Q2 2026.
The company reiterates that certain U.S. revenues are recognized on a cash basis, creating a timing lag between rising visit volumes and reported revenue. Rocket Doctor AI distinguishes between in‑network and out‑of‑network U.S. patients, allows out‑of‑network access to drive adoption, submits out‑of‑network claims where possible, and will only recognize any related revenue upon cash receipt due to collection uncertainty.
Rocket Doctor AI (AIRDF) will host a virtual Company Town Hall on Monday, September 14, 2026, to review Q2 2026 milestones and outline its growth strategy for the United States and Canada for the remainder of 2026.
The event will be co-led by CEO Dr. Essam Hamza of Rocket Doctor AI and Founder and CEO Dr. William Cherniak of Rocket Doctor Inc. The town hall, held via Zoom at 1300 Pacific / 1600 Eastern, is open to team members, key stakeholders, investors and strategic partners.
Rocket Doctor AI delivers physician-built, AI-powered healthcare solutions, including its Global Library of Medicine decision support system and a digital health platform that has supported over 350 MDs in more than 750,000 patient visits.
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) reported Q2 2026 revenue of $734,028, up 43% year over year from $512,756 and broadly in line with Q1 2026’s $737,103. Net loss widened to $6.67 million, or $0.07 per share, with Adjusted EBITDA loss at $4.12 million.
Gross margin declined to 65% from 75% in Q1 2026 and 89% in Q2 2025, reflecting a changing revenue mix as U.S. operations scale. U.S. completed patient visits rose to 3,911, a 196% increase from 1,319 in Q1, while total U.S. in-network reach expanded to about 24 million covered lives across California, New York, and Maryland.
Canada remained a core market with completed visits rising 23% year over year to 45,766. As of June 30, 2026, cash and equivalents were $0.95 million, up from $0.64 million at December 31, 2025. Subsequent to quarter-end, the company raised roughly CAD$3.26 million via oversubscribed unsecured convertible debentures, secured additional NIH funding exceeding US$500,000 in total, achieved SOC 2 Type 1 compliance, expanded multiple U.S. payer and network agreements, and appointed a new Chief Financial Officer.
Rocket Doctor AI (CSE:AIDR, OTC:AIRDF, Frankfurt:939) announced that doctors using its subsidiary Rocket Doctor Inc.’s digital health platform have entered a strategic provider network agreement with a leading national technology-enabled network partner in California, effective July 1, 2026, with an initial one‑year term and automatic annual renewals.
The agreement grants participation across five network channels—Primary, Complementary, Workers’ Compensation, Auto Medical and Medicare Advantage—providing access to upstream insurers, employer health plans and other organizations, subject to participation and eligibility requirements. The national network serves more than 700 health plans, over 100,000 employers, about 60 million consumers and approximately 1.4 million providers, giving Rocket Doctor a single contracted pathway into multiple U.S. healthcare and reimbursement channels, including California’s telehealth-supported workers’ compensation and auto medical markets.
Rocket Doctor AI (OTC:AIRDF) announced that physicians using its subsidiary Rocket Doctor’s digital health platform have entered into an agreement with a major national insurer to expand in-network, physician-led virtual care for eligible Medicare Advantage PPO and commercial plan members in New York.
The deal adds access for more than 100,000 eligible covered lives in the New York City metro area and select upstate counties, plus eligible out-of-state members via a reciprocal network program. Rocket Doctor now reaches about 10 million covered lives in New York and 24 million across the U.S. The agreement, signed July 15, 2026, has an initial one-year term with automatic yearly renewals.
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) has entered into a digital advisory agreement with B2i Digital, subject to Canadian Securities Exchange approval, to provide investor-focused digital marketing services and feature Rocket Doctor AI in B2i Digital’s program connected to a network of over 1.7 million market participants.
B2i Digital will build and maintain a featured company profile, run paid digital advertising, develop investor-focused content, distribute it across major social media platforms, execute email campaigns, and connect Rocket Doctor AI with investor conferences and speaking opportunities. The initial term is three months, expected to start around August 5, 2026, with a total cash fee of $21,375 USD payable at commencement.
Rocket Doctor AI may extend the agreement within the first month to six months for an additional $14,625 USD or to twelve months for an additional $32,625 USD. Compensation is entirely cash-based with no options to purchase Rocket Doctor AI securities.
Rocket Doctor AI (CSE:AIDR, OTC:AIRDF) announced that its subsidiary Rocket Doctor has extended its engagement with the EngageWell Network to expand physician-led virtual care for low-income, uninsured and underinsured adults across New York City. The renewed engagement follows the New York Health Foundation-funded “Virtual Pathway to Care” pilot, which connected more than 400 underserved New Yorkers to virtual urgent care, preventive health consultations, psychiatric evaluations and primary care navigation.
The extended agreement took effect on July 1, 2026 and is aligned with related grant-funded telehealth initiatives through October 31, 2029. Rocket Doctor will work toward billing Medicaid directly where eligible, while maintaining no-cost access for participating patients. The partnership also aligns with the partners’ CVS Health Foundation-supported Healthy Aging Program, which runs through October 31, 2029 and targets 750 mental health assessments, 750 cognitive assessments and 750 heart health consultations, all free to adults aged 60 and older.
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) announced that its wholly owned subsidiary Rocket Doctor Inc. has been selected from more than 330 applicants as one of Canada’s Top 100 AI & Tech Startups for ALL IN 2026, the country’s largest AI and advanced technologies event.
The digital health platform will showcase its AI-powered, physician-led virtual care solutions at ALL IN in Montréal on September 16–17, 2026. Rocket Doctor Inc. supports over 350 physicians and has enabled more than 750,000 patient visits across North America, focusing on rural, remote and underserved communities, and leveraging its Global Library of Medicine decision-support system and intelligent clinical workflows.
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) announced that its wholly owned subsidiary, Rocket Doctor Inc., has joined the Alliance for Connected Care’s Telehealth Voters Pledge, a national coalition advocating for permanent Medicare telehealth legislation in the United States.
Co‑Founder and COO Harry Cherniak is scheduled to travel to Washington, D.C. on July 23, 2026 to join healthcare leaders, clinicians, patient advocates, and industry organizations in presenting the pledge to Members of Congress. The initiative seeks to replace temporary Medicare telehealth extensions with long-term policy, aiming to reduce uncertainty for patients and providers.
According to the company, Rocket Doctor’s platform has supported over 750,000 patient visits and empowered more than 350 physicians across Canada and the U.S., and is now in‑network with U.S. payers representing about 21 million covered lives in California, New York, and Maryland.
Rocket Doctor AI (CSE:AIDR, OTC:AIRDF, Frankfurt:939) announced that its wholly owned digital health platform Rocket Doctor has achieved SOC 2 Type I compliance following an independent audit. The certification validates controls for security, availability, confidentiality and privacy as the company expands its healthcare services across North America.
According to Rocket Doctor AI, the audit reviewed information security, access management, data privacy, incident response, business continuity, risk management, governance, and secure development/change management processes. The company has begun working toward SOC 2 Type II compliance to assess the ongoing operational effectiveness of these controls.